4-Fluorobenzoyl-A20FMDV2 X-NAVPNLRGDLQVLAQKVART-amide

Description

A20FMDV2, a peptide derived from the foot and mouth disease virus, inhibits the epithelial-specific integrin αvβ6 and here is labelled with 4-fluorobenzoyl as the light version of the PET ligand 4-[18F]Fluorobenzoyl A20FMDV2 which can be used for in vivo imaging.

See full description

Catalogue number crb1001305
Sequence (one letter code) X-NAVPNLRGDLQVLAQKVART-amide
Sequence (three letter code) X-Asn-Ala-Val-Pro-Asn-Leu-Arg-Gly-Asp-Leu-Gln-Val-Leu-Ala-Gln-Lys-Val-Ala-Arg-Thr-NH2
Modifications where X is 4-fluorobenzoyl
Disease Area Foot and mouth disease
Purity >95%
Storage -20°C
Molecular Weight 2283.3
References

Hausner et al (2007) Use of a Peptide Derived from Foot-and-Mouth Disease Virus for the Noninvasive Imaging of Human Cancer: Generation and Evaluation of 4-[18F]Fluorobenzoyl A20FMDV2 for In vivo Imaging of Integrin αvβ6 Expression with Positron Emission Tomography. Cancer Res. 67(16) doi: 10.1158/0008-5472.CAN-07-1026

A20FMDV2, a peptide derived from the foot and mouth disease virus, inhibits the epithelial-specific integrin αvβ6 and here is labelled with 4-fluorobenzoyl as the light version of the PET ligand 4-[18F]Fluorobenzoyl A20FMDV2 which can be used for in vivo imaging.

4-Fluorobenzoyl-A20FMDV2

Cat No. Pack Size Price Qty

crb1001305h

0.5mg

$127.50

crb1001305j

1mg

$165.00